125 related articles for article (PubMed ID: 8649871)
1. Unique nuclear matrix protein alterations in head and neck squamous cell carcinomas: intermediate biomarker candidates.
Donat TL; Sakr W; Lehr JE; Pienta KJ
Otolaryngol Head Neck Surg; 1996 Mar; 114(3):387-93. PubMed ID: 8649871
[TBL] [Abstract][Full Text] [Related]
2. Nuclear matrix proteins as malignant markers in squamous cell carcinoma of the head and neck.
McCaffery JD; Gapany M; Faust RA; Davis AT; Adams GL; Ahmed K
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):283-8. PubMed ID: 9076234
[TBL] [Abstract][Full Text] [Related]
3. Nuclear matrix proteins in normal and breast cancer cells.
Khanuja PS; Lehr JE; Soule HD; Gehani SK; Noto AC; Choudhury S; Chen R; Pienta KJ
Cancer Res; 1993 Jul; 53(14):3394-8. PubMed ID: 8324750
[TBL] [Abstract][Full Text] [Related]
4. The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck.
Nylander K; Dabelsteen E; Hall PA
J Oral Pathol Med; 2000 Oct; 29(9):413-25. PubMed ID: 11016683
[TBL] [Abstract][Full Text] [Related]
5. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.
Topf MC; Tuluc M; Harshyne LA; Luginbuhl A
J Immunother Cancer; 2017 Jul; 5(1):60. PubMed ID: 28716144
[TBL] [Abstract][Full Text] [Related]
6. MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: emerging evidence and therapeutic perspectives.
Marioni G; Staffieri C; Staffieri A; De Filippis C; Blandamura S
Acta Otolaryngol; 2009 May; 129(5):476-80. PubMed ID: 18615330
[TBL] [Abstract][Full Text] [Related]
7. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors.
Nadal A; Campo E; Pinto J; MallofrĂ© C; PalacĂn A; Arias C; Traserra J; Cardesa A
J Pathol; 1995 Feb; 175(2):181-8. PubMed ID: 7738713
[TBL] [Abstract][Full Text] [Related]
8. Expression of ER-D5 and EGFr in laryngeal carcinoma and pre-malignant epithelium.
Maiorano E; Botticella MA; Marzullo A; Resta L
Acta Otolaryngol Suppl; 1997; 527():95-9. PubMed ID: 9197492
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Dai Y; Liu Y; Tian X; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
[TBL] [Abstract][Full Text] [Related]
11. Expression of extracellular matrix metalloprotease inducer in laryngeal squamous cell carcinoma.
Rosenthal EL; Shreenivas S; Peters GE; Grizzle WE; Desmond R; Gladson CL
Laryngoscope; 2003 Aug; 113(8):1406-10. PubMed ID: 12897567
[TBL] [Abstract][Full Text] [Related]
12. Nuclear matrix proteins in human colon cancer.
Keesee SK; Meneghini MD; Szaro RP; Wu YJ
Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1913-6. PubMed ID: 8127905
[TBL] [Abstract][Full Text] [Related]
13. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Fasanaro E; Tealdo G; Zanotti C; Randon B; Giacomelli L; Stellini E; Blandamura S
J Clin Pathol; 2017 Dec; 70(12):1033-1037. PubMed ID: 28446541
[TBL] [Abstract][Full Text] [Related]
14. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
[TBL] [Abstract][Full Text] [Related]
15. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
[TBL] [Abstract][Full Text] [Related]
17. [Dectection of G3BP and CD44v6 in the tissues of laryngeal squamous cell carcinoma and their clinical significance].
Luo D; Lou W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):977-982. PubMed ID: 28712408
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of epidermal growth factor receptor in laryngeal squamous cell carcinomas.
Christensen ME; Therkildsen MH; Hansen BL; Hansen GN; Bretlau P
Acta Otolaryngol; 1992; 112(4):734-8. PubMed ID: 1442018
[TBL] [Abstract][Full Text] [Related]
19. Integrin expression in head and neck cancers.
Cortesina G; Sacchi M; Bussi M; Panizzut B; Ferro S; Carlevato MT; Marchisio PC
Acta Otolaryngol; 1995 Mar; 115(2):328-30. PubMed ID: 7610834
[TBL] [Abstract][Full Text] [Related]
20. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]